Newron Pharmaceuticals (NWPHF) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free NWPHF Stock Alerts $8.52 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNewron Pharmaceuticals (OTCMKTS:NWPHF) & Tenax Therapeutics (NASDAQ:TENX) Head-To-Head Surveyamericanbankingnews.com - April 25 at 1:40 AMData from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)finance.yahoo.com - April 8 at 8:44 AMNewron Presents 2023 Financial Results and Provides 2024 Outlookfinance.yahoo.com - March 19 at 9:56 AMNewron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreementfinance.yahoo.com - March 15 at 8:47 AMBreakeven Is Near for Newron Pharmaceuticals S.p.A. (VTX:NWRN)finance.yahoo.com - March 13 at 9:52 AMNewron Reports Exceptional One-year Results of Study 014/15 With Evenamide in Treatment-resistant Schizophrenia (TRS)finance.yahoo.com - January 4 at 8:36 AMNewron enrols all subjects in schizophrenia treatment trialmsn.com - January 2 at 1:36 PMEQS-News: Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamidemarkets.businessinsider.com - December 29 at 7:03 AMNewron Pharmaceuticals SpA NWRNmorningstar.com - December 13 at 5:58 PMNewron TRS Study 6 Months’ Results: Evenamide Substantially Improves Patients to an Extent That They No Longer Meet Protocol Entry Criteriafinance.yahoo.com - October 9 at 8:12 AMNewron to Present Three Posters on Its Clinical Program Evaluating Evenamide in the Treatment of Schizophrenia at the 36 th European College of Neuropsychopharmacology Congressbusinesswire.com - October 4 at 2:05 PMNewron to Present Three Posters on Its Clinical Program Evaluating Evenamide in the Treatment of Schizophrenia at the 36th European College of Neuropsychopharmacology Congressfinance.yahoo.com - October 4 at 9:04 AMEQS-News: Newron appoints Margarita Chavez as board advisormarkets.businessinsider.com - October 2 at 7:21 AMNewron Appoints Margarita Chavez as Board Advisorfinance.yahoo.com - October 2 at 7:21 AMNewron Announces H1 2023 Results and Provides R&D Updatefinance.yahoo.com - August 4 at 6:59 PMEQS-News: Newron announces H1 2023 results and provides R&D updatemarkets.businessinsider.com - August 4 at 4:34 AMInvesting in Newron Pharmaceuticals (VTX:NWRN) a year ago would have delivered you a 187% gainfinance.yahoo.com - June 15 at 10:20 AMEQS-News: Newron announces Senior Management Team changesmarkets.businessinsider.com - May 2 at 8:13 AMNewron announces Senior Management Team changesuk.finance.yahoo.com - May 2 at 1:38 AMAnalysts Expect Newron Pharmaceuticals S.p.A. (VTX:NWRN) To Breakeven Soonfinance.yahoo.com - April 27 at 10:50 AMNewron announces AGM 2023 resultsuk.finance.yahoo.com - April 18 at 9:15 AMEQS-News: Newron announces AGM 2023 resultsmarkets.businessinsider.com - April 18 at 9:15 AMEQS-News: Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatrymarkets.businessinsider.com - March 28 at 1:45 PMNewron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatryuk.finance.yahoo.com - March 28 at 8:45 AMEQS-News: Newron to present at the 31st European Congress of Psychiatrymarkets.businessinsider.com - March 17 at 1:01 PMNewron announces 2022 financial results and provides outlook for 2023uk.finance.yahoo.com - March 14 at 2:27 AMNewron: Managing India’s Next-gen of Modern Schoolsmsn.com - February 13 at 8:44 AMNewron Pharmaceuticals (VTX:NWRN) soars 117% this week, taking one-year gains to 104%ca.finance.yahoo.com - January 6 at 5:09 PMNewron Pharmaceuticals S.p.A.wsj.com - December 22 at 11:39 PMAnalysts Expect Breakeven For Newron Pharmaceuticals S.p.A. (VTX:NWRN) Before Longfinance.yahoo.com - October 31 at 9:24 AMNewron provides H1 2022 results and updates on R&D and business activitiesuk.finance.yahoo.com - September 15 at 2:38 AMNewron provides H1 2022 results and updates on R&D and business activitiesuk.finance.yahoo.com - September 15 at 2:38 AMDGAP-News: Newron provides H1 2022 results and updates on R&D and business activitiesmarkets.businessinsider.com - September 15 at 2:38 AMDGAP-News: Newron extends Senior Management team and strengthens commitment to ESGmarkets.businessinsider.com - July 1 at 3:12 AMNewron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia (TRS) at the 33rd CINP Hybrid World Congress of Neuropsychopharmacologyfinance.yahoo.com - June 7 at 10:37 AMDGAP-News: Newron announces 2021 financial results and provides outlook for 2022markets.businessinsider.com - March 15 at 4:37 AMNewron Pharmaceuticals Spa. (NWPHF)nasdaq.com - January 19 at 11:02 PMChange in Newron Board of Directorsuk.finance.yahoo.com - December 1 at 8:11 PMEQS-Adhoc: Change in Newron Board of Directorsmarkets.businessinsider.com - December 1 at 3:04 PMDGAP-News: Change in Newron Board of Directorsmarkets.businessinsider.com - December 1 at 3:04 PMNewron Receives Fifth Tranche from Financing Agreement with European Investment Bank (EIB)finance.yahoo.com - October 18 at 2:44 PMNewron Announces Half-Year 2021 Resultsfinance.yahoo.com - September 16 at 9:33 AMNewron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB)finance.yahoo.com - September 6 at 5:01 PM Get Newron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NWPHF and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here NWPHF Media Mentions By Week NWPHF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NWPHF News Sentiment▼0.000.44▲Average Medical News Sentiment NWPHF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NWPHF Articles This Week▼10▲NWPHF Articles Average Week Get Newron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NWPHF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ProMIS Neurosciences News Today Cara Therapeutics News Today BriaCell Therapeutics News Today Unicycive Therapeutics News Today Marker Therapeutics News Today Eledon Pharmaceuticals News Today Clene News Today VYNE Therapeutics News Today ImmunoPrecise Antibodies News Today Fortress Biotech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NWPHF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport Society1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Newron Pharmaceuticals S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
